IDAHO OVERDOSE DATA TO ACTION - Project Abstract Purpose The purpose of Idaho’s Overdose Data to Action in States funding application is to build upon efforts currently being implemented across the state to combat the overdose epidemic in Idaho and ensure an interdisciplinary, comprehensive, cohesive public health approach to reduce opioid and stimulant use and misuse in Idaho. By increasing access to timely data related to prescribing and fatal and non-fatal drug overdoses, stakeholders will better understand the scope, direction, and contours of the epidemic in Idaho resulting in data-driven decision making to support the implementation of informed and targeted, prevention and response efforts. Outcomes All strategies support the following long-term outcomes: • Decreased fatal drug overdoses • Decreased nonfatal drug overdoses • Decreased illicit opioid and stimulant use, including co-use with other substances, Opioid Use Disorder (OUD), and Stimulant Use Disorder (StUD) • Increased uptake of evidence-based treatment and retention with long-term recovery supports, with a primary focus on OUD and StUD • Improved health equity among groups disproportionately affected by the overdose epidemic and those previously underserved by overdose prevention programs and the healthcare system • Decreased stigma related to substance use and overdose Specifically, Idaho will: 1) Enhance the statewide detection of drug overdose spikes, 2) Improve specificity on death certificates, 3) Increase surveillance efforts, 4) Increase ability to make data-driven decisions, 5) Improve the dissemination and response time of data, 6) Enhance surveillance data and the delivery of that data to stakeholders, 7) Increase use of the PDMP, 8) Decrease risky prescribing behaviors, 9) Increase the use of non-opioid and non-pharmacologic treatments for pain, 10) Increase access to harm reduction resources and services, 11) Increase collaboration efforts between public health and public safety 12) Increase referrals to, and engagement in, treatment, and 13) Decrease stigma associated with substance use and substance use disorder.